期刊論文(共計49筆) |
序號 | 學年度 | 學期 | 年度 | 月份 | 作者 | 題目 | 通訊作者 | 作者順位 | 期刊名稱 | 卷數 | 頁數 | 關鍵字 |
1 | 091 | 1 | 2003 | 1 | Lin, Y.-W., Chuang, S.-M., and Yang, J.-L. | Persistent activation of ERK1/2 by lead acetate increase nucleotide excision repair synthesis and confers anti-cytotoxicity and anti-mutagenicity. | 是 | 其他 | Carcinogenesis | 24 | 53-61 | |
2 | 091 | 2 | 2003 | 6 | Lin, Y.-W., Chuang, S.-M., and Yang, J.-L. | ERK1/2 achieves sustained activation by stimulating MAPK phosphatase-1 degradation via the ubiquitin-proteasome pathway. | 是 | 第一順位 | J. Biol. Chem. | 278 | 21534-21541 | |
3 | 094 | 1 | 2006 | 1 | Lin, Y.-W. and Yang, J.-L. | Proteolysis of Dual-Specificity MAPK Phosphatase MKP-1/CL100/DUSP1 via ERK Phosphorylation and SCFSkp2 Ubiquitination.
| 否 | 第一順位 | J. Biol. Chem. | 281 | 915-926 | |
4 | 096 | 1 | 2008 | 1 | Li JP, Wang CY, Tang YA, Lin YW, Yang JL*. | Role of extracellular signal-regulated kinase (ERK) signaling in nucleotide excision repair and genotoxicity in response to As(III) and Pb(II) | 否 | 其他 | Pure Appl. Chem. | 80 | 2735-2750 | |
5 | 097 | 1 | 2008 | 11 | Ko JC, Hong JH, Wang LH, Cheng CM, Ciou SC, Lin ST, Jheng MY, Lin YW* | Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells. | 是 | 其他 | Molecular Cancer Therapeutics | 7 | 3632-41 | |
6 | 096 | 2 | 2008 | 5 | Ko JC, Hong JH, Wang LH, Lin YW* | The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo(a)pyrene in human lung cancer. | 是 | 其他 | Experimental Cell Research | 314 | 1881-91 | |
7 | 096 | 2 | 2008 | 7 | Ko JC, Ciou SC, Cheng CM, Wang LH, Hong JH, Jheng MY, Ling ST, Lin YW* | Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells. | 是 | 其他 | Carcinogenesis | 29 | 1448-58 | |
8 | 097 | 1 | 2008 | 8 | Wang CY, Lin YW, Yang JL | Activation of protein kinase Calpha signaling prevents cytotoxicity and mutagenicity following lead acetate in CL3 human lung cancer cells. | 是 | 第二順位 | Toxicology | 250 | 55-61 | |
9 | 097 | 1 | 2008 | 8 | Chuang SM, Wang LH, Hong JH, Lin YW* | Induction of Rad51 protein levels by p38 MAPK decreases cytotoxicity and mutagenicity in benzo(a)pyrene-exposed human lung cancer cells. | 是 | 其他 | Toxicology and Applied Pharmacology | 230 | 290-7 | |
10 | 098 | 1 | 2009 | 12 | Huang S, Chueh PJ, Lin YW, Shih TS, Chuang SM | Disturbed mitotic progression and genome segregation are involved in cell transformation mediated by nano-TiO2 long-term exposure. | 否 | 第三順位 | Toxicol Appl Pharmacol | 241 | 182-94 | |
11 | 098 | 1 | 2009 | 8 | Ko JC, Ciou SC, Jhan JY, Cheng CM, Su YJ, Chuang SM, Lin ST, Chia-Che Chang, Lin YW*. | Roles of MKK1/2-ERK1/2 and PI3K-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells. | 是 | 其他 | Molecular Cancer Research | 7 | 1378-89 | |
12 | 098 | 1 | 2009 | 9 | Chen RS, Jhan JY, Su YJ, Lee WT, Cheng CM, Ciou SC, Lin ST, Chuang SM, Ko JC, and Lin YW*. | Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation. | 是 | 其他 | Exp Cell Res | 315 | 2658-2672 | |
13 | 098 | 1 | 2009 | 9 | Ko JC, Wang LH, Jhan JY, Ciou SC, Hong JH, Lin ST, Lin YW*. | The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells | 是 | 其他 | Lung Cancer | 65 | 290-298 | |
14 | 099 | 1 | 2010 | 12 | Tsai MS, Kuo YH, Chiu YF, Su YC, Lin YW* | Downregulation of Rad51 expression overcomes drug resistance to gemcitabine in human non-small cell lung cancer cells. | 是 | 其他 | The Journal of Pharmacology and Experimental Therapeutics | 335 | 830-840 | |
15 | 098 | 2 | 2010 | 2 | Ko JC, Su YJ, Lin ST, Jhan JY, Ciou SC, Cheng CM, Lin YW*. | Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells. | 是 | 其他 | Biochemical Pharmacology | 79 | 655-664 | |
16 | 098 | 2 | 2010 | 4 | Su YJ, Tsai MS, Kuo YH, Chiu YF, Cheng CM, Lin ST, Lin YW*. | Role of Rad51 Down-Regulation and Extracellular Signal-Regulated Kinases 1 and 2 Inactivation in Emodin and Mitomycin C-Induced Synergistic Cytotoxicity in Human Non–Small-Cell Lung Cancer Cells. | 是 | 其他 | Molecular Pharmacology | 77 | 633-643 | |
17 | 098 | 2 | 2010 | 4 | Lin YW, Yang FJ, Chen CL, Lee WT, Chen RS*. | Free radical scavenging activity and antiproliferative potential of Polygonum cuspidatum root extracts. | 否 | 第一順位 | Journal of Natural Medicines | 64 | 146-152 | |
18 | 099 | 1 | 2010 | 8 | Ko JC, Su YJ, Lin ST , Jhan JY, Ciou SC, Cheng CM, Chiu YF, Kuo YH, Tsai MS, Lin YW*. | Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2. | 是 | 其他 | Lung Cancer | 69 | 155-164 | |
19 | 099 | 2 | 2011 | 3 | Ko JC, Tsai MS, Kuo YH, Chiu YF, Su YC, Lin YW*. | Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin resulte in synergistic cytotoxic effect in combination with capecitabine. | 是 | 其他 | Biochemical Pharmacology | 81 | 680-690 | |
20 | 099 | 2 | 2011 | 7 | Ko JC, Tsai MS, Chiu YF, Weng SH, Kuo YH, Lin YW* | Up-regulation of ERK1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small cell lung cancer cells | 是 | 其他 | The Journal of Pharmacology and Experimental Therapeutics | 338 | 184-194 | |
21 | 099 | 2 | 2011 | 7 | Tsai MS, Weng SH, Kuo YH, Chiu YF, Lin YW*. | Synergistic effect of curcumin and cisplatin via downregulation of thymidine phosphorylase and excision repair cross-complementary 1 (ERCC1). | 是 | 其他 | Molecular Pharmacology | 80 | 136-146 | |
22 | 100 | 1 | 2011 | 9 | Shen YH, Chen BR, Cherng SH, Chueh PJ, Tan X, Lin YW, Lin JC, Chuang SM*. | Cisplatin transiently up-regulates hHR23 expression through enhanced translational efficiency in A549 adenocarcinoma cells. | 否 | 其他 | Toxicol Lett. | 205 | 341-350 | |
23 | 100 | 1 | 2011 | 9 | Ko JC, Tsai MS, Weng SH, Kuo YH, Chiu YF, Lin YW*. | Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells. | 是 | 其他 | Toxicol Appl Pharmacol | 255 | 327-38 | |
24 | 101 | 1 | 2012 | 12 | 3. Ko JC, Chen HJ, Huang YC, Tseng SC, Weng SH, Wo TY, Huang YJ, Chiu HC, Tsai MS, Chiou Y.Y., Lin Y | HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells. | 是 | 其他 | Regulatory Toxicology and Pharmacology | 64 | 415-424 | |
25 | 100 | 2 | 2012 | 3 | Weng SH, Tsai MS, Chiu YF, Kuo YH, Chen HJ, Lin YW* | Enhancement of mitomycin C-induced cytotoxicity by curcumin results from downregulation of MKK1/2-ERK1/2-mediated thymidine phosphorylase expression. | 是 | 其他 | Basic Clinical Pharmacology Toxicology | 110 | 298-306 | |
26 | 100 | 2 | 2012 | 3 | Tsai MS, Weng SH, Chen HJ, Chiu YF, Huang YC, Tseng SC, Kuo YH, Lin YW* | Inhibition of p38 MAPK–dependent excision repair cross-complementing 1 expression decreases the DNA repair capacity to sensitize lung cancer cells to etoposide. | 是 | 其他 | Molecular Cancer Therapeutics | 11 | 561-571 | |
27 | 100 | 2 | 2012 | 7 | Weng SH, Tseng SC, Huang YC, Chen HJ, Lin YW*. | Inhibition of thymidine phosphorylase expression by using an HSP90 inhibitor potentiates the cytotoxic effect of cisplatin in non-small-cell lung cancer cells. | 是 | 其他 | Biochemical Pharmacology | 84 | 126-136 | |
28 | 100 | 2 | 2012 | 7 | Lu CH, Lin SC, Yang SY, Pan MY, Lin YW, Hsu CY, Wei YH, Chang JS, Chang CC*. | Toxicol Lett. | 否 | 其他 | Toxicol Lett. | 121 | 83-89 | |
29 | 102 | 1 | 2013 | 12 | Chen RS, Ko JC, Chiu HC, Wo TY, Huang YJ, Tseng SC, Chen HJ, Huang YC, Jian YJ, Lee WT, Lin YW*. | Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells | 是 | 其他 | Naunyn Schmiedebergs Archives of Pharmacology | 386 | 1047-1059 | |
30 | 102 | 1 | 2013 | 12 | Ko JC, Chiu HC, Wo TY, Huang YJ, Tseng SC, Huang YC, Chen HJ, Syu JJ, Chen CY, Jian YT, Jian YJ, | Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells | 是 | 其他 | Lung Cancer | 82 | 397-406 | |
31 | 101 | 2 | 2013 | 2 | Tseng SC, Huang YC, Chen HJ, Chiu HC, Huang YJ, Wo TY, Weng SH, Lin YW* | Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel. | 是 | 其他 | Biochemical Pharmacology | 85 | 583-594 | |
32 | 101 | 2 | 2013 | 7 | Ko JC, Huang YC, Chen HJ, Tseng SC, Chiu HC, Wo TY, Huang YJ, Weng SH, Chiou Y.Y., Lin YW* | Ko JC, Huang YC, Chen HJ, Tseng SC, Chiu HC, Wo TY, Huang YJ, Weng SH, Chiou Y.Y., Lin YW* | 是 | 其他 | Basic Clinical Pharmacology Toxicology | 113 | 56-65 | |
33 | 102 | 2 | 2014 | 3 | Ko JC, Chiu HC, Syu JJ, Jian YJ, Chen CY, Jian YT, Huang YJ, Wo TY, Lin YW* | Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells. | 是 | 其他 | Biochemical Pharmacology | 88 | 119-127 | |
34 | 102 | 2 | 2014 | 4 | Tung CL, Chiu HC, Jian YJ, Jian YT, Chen CY, Syu JJ, Wo TY, Huang YJ, Tseng SC, Lin YW* | Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cells | 是 | 其他 | Experimental Cell Research | 322 | 345-354 | |
35 | 103 | 1 | 2015 | 1 | Ko JC, Chiu HC, Syu JJ, Chen CY, Jian YJ, Huang YJ, Wo TY, Jian YJ, Chang PY, Wang TJ, and Lin YW | Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells. | 是 | 其他 | Biochemical and Biophysical Research Communications | 456 | 506-512 | |
36 | 104 | 1 | 2015 | 10 | Ko JC, Wang TJ, Chang PY, Syu JJ, Chen JC, Chen CY, Jian YT, Jian YJ, Zheng HY, Chen WC, Lin YW | Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cells. | 是 | 其他 | Biochemical Pharmacology | 97 | 331-340 | |
37 | 104 | 1 | 2015 | 12 | Ko JC, Syu JJ, Chen JC, Wang TJ, Chang PY, Chen CY, Jian YT, Jian YJ, and Lin YW* | Resveratrol enhances etoposide-induced cytotoxicity through down-regulating ERK1/2 and AKT-mediated X-ray repair cross-complement group 1 (XRCC1) protein expression in human non-small-cell lung cancer cells | 是 | 其他 | Basic Clinical Pharmacology Toxicology | 117 | 383-391 | |
38 | 103 | 2 | 2015 | 5 | Tung CL, Jian YJ, Syu JJ, Wang TJ, Chang PY, Chen CY, Jian YT, and Lin YW* | Down-regulation of ERK1/2 and AKT-mediated X-ray repair cross-complement group 1 protein (XRCC1) expression by Hsp90 inhibition enhances the gefitinib-induced cytotoxicity in human lung cancer cells | 是 | 其他 | Experimental Cell Research | 334 | 126-135 | |
39 | 105 | 1 | 2016 | 12 | Ko JC, Zheng HY, Chen WC, Peng YS, Wu CH, CL Wei, JC Chen, and Lin YW* | Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression. | 是 | 其他 | Biochemical Pharmacology | 122 | 90-98 | |
40 | 104 | 2 | 2016 | 3 | Tung CL, Jian YJ, Chen JC, Wang TJ, Chen WC, Zheng HY, Chang PY, Liao KS, and Lin YW* | Curcumin downregulates p38 MAPK–dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells | 是 | 其他 | Naunyn-Schmiedebergs Archives of Pharmacology | 389 | 657-66 | |
41 | 104 | 2 | 2016 | 4 | 2. Ko JC, Chen JC, Wang TJ, Zheng HY, Chen WC, Chang PY, and Lin YW* | Astaxanthin down-regulates Rad51 expression via inactivation of AKT kinase to enhance mitomycin C-induced cytotoxicity in human non-small cell lung cancer cells | 是 | 其他 | Biochemical Pharmacology | 105 | 91-100 | |
42 | 105 | 1 | 2016 | 9 | Liao KS, Wei CL, Chen JC, Zheng HY, Chen WC, Wu CH, Wang TJ, Peng YS, Chang PY, and Lin YW* | Astaxanthin enhances pemetrexed-induced cytotoxicity by downregulation of thymidylate synthase expression in human lung cancer cells. 2016 Sep 28;81:353-361. | 是 | 其他 | Regulatory Toxicology and Pharmacology | 81 | 353-361 | |
43 | 106 | 1 | 2017 | 12 | Ko JC, Peng YS, Wu CH, Chen JC, Zheng HY, Lin YC, Ma PF, Chen WC, and Lin YW* | Down-Regulation of MutS Homolog 2 (MSH2) Expression by Curcumin Enhances Cytotoxicity Induced by Gemcitabine in Human Lung Adenocarcinoma Cells. | 是 | 其他 | Epidemiology | 7 | 1000332 | |
44 | 106 | 1 | 2017 | 8 | Tung CL, Chen JC, Wu CH, Peng YS, Chen WC, Zheng HY, Jian YJ, Wei CL, Cheng YT, and Lin YW* | Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cells | 是 | 其他 | Exp Cell Res | 357 | 59-66 | |
45 | 106 | 2 | 2018 | 6 | Chen JC, Ma PF, Lin YC, Wu CH, Peng YS, Zheng HY, Lin MC, Li YT, Lin YW* | 17-(Allylamino)-17-Demethoxygeldanamycin Enhances Etoposide-Induced Cytotoxicity via the Downregulation of Xeroderma Pigmentosum Complementation Group C Expression in Human Lung Squamous Cell Carcinoma Cells | 是 | 其他 | Pharmacology | 102 | 91-104 | |
46 | 107 | 1 | 2018 | 9 | Chen JC, Wu CH, Peng YS, Zheng HY, Lin YC, Ma PF, Yen TC, Chen TY, Lin YW* | Astaxanthin enhances erlotinib-induced cytotoxicity by p38 MAPK mediated xeroderma pigmentosum complementation group C (XPC) down-regulation in human lung cancer cells | 是 | 其他 | Toxicology Research | 7 | 1247–1256 | |
47 | 107 | 2 | 2019 | 2 | Ko JC, Chen JC, Chen TY, Yen TC, Ma PF, Lin YC, Wu CH, Peng YS, Zheng HY, Lin YW* | Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells | 是 | 其他 | Toxicology | 417 | 54-63 | |
48 | 107 | 2 | 2019 | 3 | Chen JC, Ko JC, Yen TC, Chen TY, Lin YC, Ma PF, and Lin YW* | Capsaicin enhances erlotinib-induced cytotoxicity via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells | 是 | 其他 | Toxicology Research | 8 | 459-470 | |
49 | 108 | 2 | 2020 | 3 | Ko JC, Chen JC, Yen TC, Chen TY, Ma PF, Lin YC, Cheng HH, Taso YC, and Lin YW* | Nitroglycerin enhances cisplatin-induced cytotoxicity via AKT inactivation and thymidylate synthase down-regulation in human lung cancer cells | 是 | 其他 | Pharmacology | 105 | 209-224 | |
會議論文(共計36筆) |
序號 | 學年度 | 學期 | 年度 | 月份 | 作者 | 題目 | 通訊作者 | 作者順位 | 發表性質 | 會議論文集或研討會名稱 | 地點 |
1 | 090 | 1 | 2001 | 10 | Lin, Y.-W., and Yang, J.-L. | Activation of ERK by lead acetate confers anti-cytotoxixity and anti-mutagenicity in cultured human cells. | 否 | 第一順位 | 壁報發表 | 8th International Conference on Environmental Mutagens | Shizuoka, Japan |
2 | 090 | 1 | 2001 | 10 | Yang, J.-L., Liou, G.-Y., Lin, Y.-W., Chuang, S.-M., and Chen, R.-H. | Roles of three mitogen-activated protein kinase in UV-induced mutagenesis. | 否 | 其他 | 壁報發表 | 8th International Conference on Environmental Mutagens | Shizuoka, Japan |
3 | 093 | 2 | 2005 | 7 | Yun-Wei Lin and Jai-Ling Yang. | Proteolysis of Dual-Specificity MAPK Phosphatase MKP-1/CL100/DUSP1 via ERK Phosphorylation and SCFSkp2 Ubiquitination. | 否 | 第一順位 | 壁報發表 | FASEB Summer Research Conferences | Snowmass, Colorado |
4 | 096 | 1 | 2007 | 11 | Lyu-Han Wang, Jhao-Hao Hong, and Yun-Wei Lin. | p38 MAPK activation by benzo(a)pyrene increase Rad51 protein level and prevent cytotoxicity and mutagenicity in human lung cancer cells. | 是 | 其他 | 書面發表 | The 1st International Cancer Symposium | Taiwan, China Medical University and Hospital |
5 | 096 | 2 | 2008 | 4 | Jen-Chung Ko, Jhao-Hao Hong, Lyu-Han Wang and Yun-Wei Lin. | The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo(a)pyrene in human lung cancer. | 是 | 其他 | 壁報發表 | American Association for Cancer Research Annual Meeting | San Diego Convention Center, San Diego, CA. |
6 | 096 | 2 | 2008 | 4 | Show-Mei Chuang, Lyu-Han Wang, Jhao-Hao Hong, and Yun-Wei Lin. | Induction of Rad51 protein levels by p38 MAPK decreases cytotoxicity and mutagenicity in benzo(a)pyrene-exposed human lung cancer cells. | 是 | 其他 | 書面發表 | American Association for Cancer Research Annual Meeting. | San Diego Convention Center, San Diego, CA. |
7 | 096 | 2 | 2008 | 5 | Jhao-Hao Hong and Yun-Wei Lin. | The Role of Rad51 in Benzo(a)pyrene and Epidermal Growth Factor Receptor Inhibitor (Gefitinib, Iressa) Induced Synergistic Cytotoxicity in Human Lung Cancer. | 是 | 其他 | 書面發表 | The 23rd Joint Annual Conference of Biomedical sciences | National Defence Medical Center, Taiwan. |
8 | 096 | 2 | 2008 | 5 | Lyu-Han Wang and Yun-Wei Lin. | The Role of p38 MAPK and ATM/ATR Signal in Benzo(a)pyrene Induced Rad51 Gene and Protein Expression in Human Lung Cancer Cells. | 是 | 其他 | 書面發表 | The 23rd Joint Annual Conference of Biomedical sciences | National Defence Medical Center, Taiwan. |
9 | 098 | 1 | 2009 | 11 | Yun-Wei Lin, Jen-Chung Ko, Ying-Jhen Su. | Roles of MKK1/2-ERK1/2 and PI3K-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells. | 是 | 其他 | 壁報發表 | Biotechnology Taiwan 2009 Conference | Taipei, Taiwan |
10 | 098 | 1 | 2009 | 11 | Ying-Jhen Su, Szu-Ting Lin, Yun-Wei Lin. | Suppression of ercc1 and rad51 expression through erk1/2 inactivation is essential in emodin-mediated cytotoxicity in human lung cancer cells. | 是 | 其他 | 壁報發表 | Biotechnology Taiwan 2009 Conference | Taipei, Taiwan |
11 | 098 | 1 | 2009 | 11 | Min-Shao Tsai, Ying-Jhen Su, Szu-Ting Lin, Yu-Fan Chiu, Ya-Hsun Kuo, Yun-Wei Lin. | Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ercc1 and inactivation of erk1/2 in human non-small cell lung cancer cells. | 是 | 其他 | 壁報發表 | Biotechnology Taiwan 2009 Conference | Taipei, Taiwan |
12 | 097 | 2 | 2009 | 4 | Jen-Chung Ko, Chao-Min Cheng, Shih-Ci Ciou, Jhih-Yuan Jhan, Ying-Jhen Su, Show-Mei Chuang, Szu-Ting | Role of MKK1/2-ERK1/2 and PI3K-AKT signaling in erlotinib decrease Rad51 expression and cell survival in human non-small cell lung cancer cells. | 是 | 其他 | 壁報發表 | American Association for Cancer Research Annual Meeting | Colorado Convention Center, Denver, CO. |
13 | 097 | 2 | 2009 | 4 | Jhih-Yuan Jhan , Lyu-Han Wang, Shih-Ci Ciou and Yun-Wei Lin. | Role of Celecoxib in Rad51 Expression and Cell Survival Affected by Gefitinib in Human Non-Small Cell Lung Cancer Cells. | 是 | 其他 | 壁報發表 | The 24th Joint Annual Conference of Biomedical Science | Taiwan |
14 | 097 | 2 | 2009 | 4 | Chao-Min Cheng, Shih-Ci Ciou, Yun-Wei Lin. | Rad51 Regulate the Different Response to Gefitinib in Human Non-Small Cell Lung Cancer Cells. | 是 | 其他 | 壁報發表 | 24th Joint Annual Conference of Biomedical Science | Taiwan |
15 | 097 | 2 | 2009 | 4 | Shih-Ci Ciou, Chao-Min Cheng, Yun-Wei Lin. | Involvement of Rad51 in Cytotoxicity induced by Gefitinib and Chemotherapeutic agents in Human Lung Cancer Cells. | 是 | 其他 | 壁報發表 | The 24th Joint Annual Conference of Biomedical Science | Taiwan |
16 | 098 | 2 | 2010 | 2 | Su YJ, Tsai MS, Kuo YH, Chiu YF, Cheng CM, Lin ST, Lin YW. | Role of Rad51 downregulation and ERK1/2 inactivation in emodin and mitomycin C-induced synergistic cytotoxicity in human non-small cell lung cancer cells. | 是 | 其他 | 壁報發表 | AACR/JCA Joint Conference: Cancer Genomics, Epigenomics, and the Development of Novel Therapeutics. | Hilton Waikoloa Village, Waikoloa, Hawaii |
17 | 099 | 2 | 2011 | 3 | Shao-Hsing Weng, Min-Shao Tsai, Yu-Fan Chiu, Ya-Hsun Kuo, and Yun-Wei Lin. | Curcumin sensitizes non-small cell lung cancer cells to cisplatin induced cytotoxicity via thymidine phosphorylase and ERCC1 downregulation. | 是 | 第一順位 | 壁報發表 | The 26th Joint Annual Conference of Biomedical Sciences | |
18 | 099 | 2 | 2011 | 3 | Min-Shao Tsai, Ya-Hsun Kuo, Yu-Fan Chiu, Shao-Hsing Weng, and Yun-Wei Lin. | Inhibition of Rad51 and ERCC1 and increase of thymidine phosphorylase by emodin enhance capecitabine-induced cytotoxicity in human non-small cell lung cancer cells. | 是 | 其他 | 壁報發表 | The 26th Joint Annual Conference of Biomedical Sciences | |
19 | 099 | 2 | 2011 | 4 | Min-Shao Tsai, Ya-Hsun Kuo, Yu-Fan Chiu, Ying-Chen Su, and Yun-Wei Lin. | Downregulation of Rad51 expression overcomes drug resistance to gemcitabine in human non-small cell lung cancer cells. | 是 | 第一順位 | 壁報發表 | Physiology Symposium 2011 | |
20 | 099 | 2 | 2011 | 4 | Yu-Fan Chiu, Min-Shao Tsai, Shao-Hsing Weng, Ya-Hsun Kuo, Yun-Wei Lin. | Up-regulation of ERK1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small cell lung cancer cells. | 是 | 其他 | 壁報發表 | Physiology Symposium 2011 | |
21 | 099 | 2 | 2011 | 4 | Min-Shao Tsai, Yu-Fan Chiu, Shao-Hsing Weng, Ya-Hsun Kuo, and Yun-Wei Lin. | Thymidylate synthase and thymidine phosphorylase expression contributes to cisplatin resistance. | 是 | 其他 | 壁報發表 | 102nd AACR Annual Meeting. | |
22 | 100 | 2 | 2012 | 3 | Yun-Wei Lin, Shao-Hsing Weng, Jen-Chung Ko, Huang-Jen Chen, Sheng-Chieh Tseng, Yu-Ching Huang, M | HSP90 inhibition induced cytotoxicity via downregulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells. | 是 | 第一順位 | 壁報發表 | AACR Annual Meeting 2012 | |
23 | 100 | 2 | 2012 | 3 | Yu-Ching Huang, Sheng-Chieh Tseng, Huang-Jen Chen, Shao-Hsing Weng, and Yun-Wei Lin*. | HSP90 inhibition induced cytotoxicity through down-regulation of Rad51 and thymidine phosphorylase expression in human non-small cell lung cancer cells. | 是 | 其他 | 壁報發表 | The 27th Joint Annual Conference of Biomedical Sciences | |
24 | 100 | 2 | 2012 | 5 | Yu-Ching Huang, Sheng-Chieh Tseng, Shao-Hsing Weng, Huang-Jen Chen, and Yun-Wei Lin | Down-regulation of thymidine phosphorylase expression by 17-AAG enhances the cytotoxic effect of cisplatin in human lung cancer cells. | 是 | 其他 | 壁報發表 | The International Symposium in Commemoration of the 5th Anniversary of College of Life Sciences | |
25 | 101 | 2 | 2013 | 4 | 林芸薇 | Role of ERCC1 in metformin enhancing paclitaxel-induced cytotoxicity. | 是 | 其他 | 壁報發表 | AACR Annual Meeting 2013 | Washington Convention Center, Washington, DC. |
26 | 101 | 2 | 2013 | 4 | 林芸薇 | Metformin induces cytotoxicity by TP and ERCC1 decrease. | 是 | 其他 | 壁報發表 | AACR Annual Meeting 2013. | Washington Convention Center, Washington, DC. |
27 | 101 | 2 | 2013 | 5 | 林芸薇 | Role of pemetrexed in DNA repair capacity and cell survival affected by resveratrol. | 是 | 其他 | 壁報發表 | IBMS-JSBMR 2013. | |
28 | 105 | 1 | 2016 | 11 | Chia-Hung Wu, Hao-Yu Zheng, Wen-Ching Chen, Yi-Shuan Peng, and Yun-Wei Lin | Role of thymidylate synthase expression in astaxanthin and pemetrexed-induced cytotoxicity in human non-small cell lung cancer cells | 是 | 其他 | 壁報發表 | 第六屆國際植物化合物暨疾病預防與功能評估研討會 | 嘉義大學 |
29 | 105 | 1 | 2016 | 11 | Yi-Shuan Peng, Hao-Yu Zheng, Wen-Ching Chen, Chia-Hung Wu, Chia-Li Wei, Jyh-Cheng Chen, and Yun-Wei | Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of thymidylate synthase expression | 是 | 其他 | 壁報發表 | 第六屆國際植物化合物暨疾病預防與功能評估研討會 | |
30 | 106 | 2 | 2018 | 3 | Yuan -Cheng Lin, Jyh -Cheng Chen, Peng -Fang Ma, Chia -Hung Wu, Yi -Shuan Peng, Hao -Yu Zheng | Curcumin Enhances Gemcitabine-induced Cytotoxicity Via Down-Regulation of MutS Homolog 2 (MSH2) Expression in Human Lung Adenocarcinoma A549 Cells | 是 | 其他 | 壁報發表 | 第33屆生物醫學聯合學術年會 | |
31 | 106 | 2 | 2018 | 3 | Peng-Fang Ma, Jyh-Cheng Chen, Yuan-Cheng Lin, Chia-Hung Wu, Yi-Shuan Peng, Hao-Yu Zheng, and Yun- | Astaxanthin enforces cytotoxicity via p38 MAPK mediated Xeroderma pigmentosum complementation group C (XPC) down-regulation in human lung cancer cells | 是 | 其他 | 壁報發表 | 第33屆生物醫學聯合學術年會 | |
32 | 108 | 1 | 2019 | 12 | Yun-Wei Lin | Role of DNA repair proteins in lung cancer chemotherapy
| 是 | 第一順位 | 口頭發表 | DDSG symposium | 日本岩手 |
33 | 107 | 2 | 2019 | 3 | 陳姿吟Tzu-Ying Chen, 林芸薇 Yun -Wei Lin* | Inhibition of thymidine phosphorylase expression by hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells. | 是 | 其他 | 壁報發表 | 第34屆生物醫學聯合學術年會 | |
34 | 107 | 2 | 2019 | 3 | 顏廷涓 Ting-Chuan Yen, 林芸薇 Yun -Wei Lin* | Capsaicin enhances erlotinib-induced cytotoxicity via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells. | 是 | 其他 | 壁報發表 | 第34屆生物醫學聯合學術年會 | |
35 | 107 | 2 | 2019 | 7 | Lin YW | Nitroglycerin induced cytotoxicity in human lung cancer cells via AKT inactivation and thymidylate synthase (TS) down-regulation. | 是 | 其他 | 壁報發表 | 23rdGlobal Annual Oncologists Meeting | |
36 | 108 | 2 | 2020 | 3 | Chen JC, Ko JC, Cheng HH, Taso YC, Yen TC, Chen TY, and Lin YW* | 17-Allylamino-Demethoxygeldanamycin enhances bevacizumab-induced cytotoxicity via Xeroderma pigmentosum complementation group C (XPC) down-regulation in human lung cancer cells | 是 | 其他 | 壁報發表 | EACR-AACR Basic and Translational Research Conference | 葡萄牙 |